Heinla K, Vasar E, Reppo I, Sedman T, Volke V
There is currently no FDA-approved GLP-1 patch on the market , and for good reason
Bariatric surgery includes options such as the gastric sleeve, gastric bypass, and duodenal switch
Although limited information currently exists regarding specific dietary reference intakes for individuals using obesity medications, a recent Joint Advisory highlights specific areas of nutritional concern for GLP-1 users (Figure 3) 27
Neurosci Appl 3:103925 Leggio L, Hendershot CS, Farokhnia M et al (2023) GLP-1 receptor agonists are promising but unproven treatments for alcohol and substance use disorders
68 Furthermore, the potential association between GLP-1 RA use and more serious GI complications such as acute pancreatitis, cholelithiasis, and bowel obstruction remains controversial due to inconsistent findings in observational studies and meta-analyses